Next Investors logo grey
  1. Home
  2. Baby Formula

Baby Formula

Leading investment firm invests in new CSIRO health technology

Finfeed Archived Aug 08, 2019

The estimated present value of benefits from the CSIRO’s work is around $3.2 billion per year, so it's no surprise that the CSIRO and the rather astute BioScience Managers would eventually cross paths.

Is JAT’s First $10M in Sales a Stepping Stone to the Trillion Dollar China Retail Market?

Next Investors Archived Oct 18, 2018

Everything is coming together for Jatenergy (ASX:JAT) as we head into the holiday season, with all roads leading to consistently increasing sales and revenues.

Jatenergy increases sales to over $10 million

Finfeed Archived Oct 17, 2018

In releasing its September quarter result, a notable takeaway from Jatenergy (ASX:JAT) was the strong revenue growth generated during the period.

Jatenergy provides update on Golden Koala production run

Finfeed Archived Oct 01, 2018

China-Australia cross-border specialist in Fast Moving Consumer Goods (FMCG) exports, Jatenergy (ASX:JAT) has published an update on its website regarding its subsidiary Golden Koala.

Join Our
Mailing List